Skip to content
10-Q

Quarterly Report

Coeptis Therapeutics, Inc.

0001683168-22-005261

← back to feed
Filed
Aug 2, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 1, 2022 39.01M sh
Shares Diluted Q2 2022 · Jun 30, 2022 38.66M sh
Shares Diluted Q2 2022 · Jun 30, 2022 38.04M sh
Shares Diluted Q2 2022 · Jun 30, 2021 30.41M sh
Shares Diluted Q2 2022 · Jun 30, 2021 29.54M sh
Capex Q2 2022 · Jun 30, 2022 $0
Capex Q2 2022 · Jun 30, 2021 $0
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$2M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$630.42K
Long Term Debt Q2 2022 · Jun 30, 2022 $150K
Long Term Debt Q2 2022 · Dec 31, 2021 $1.65M
Stockholders Equity Q2 2022 · Jun 30, 2022 $2.06M
Stockholders Equity Q2 2022 · Mar 31, 2022 $2.34M
Stockholders Equity Q2 2022 · Dec 31, 2021 $2.35M
Stockholders Equity Q2 2022 · Jun 30, 2021 −$2.14M
Stockholders Equity restated Q2 2022 · Mar 31, 2021 −$3.71M
Stockholders Equity Q2 2022 · Dec 31, 2020 −$5.14M
Current Liabilities Q2 2022 · Jun 30, 2022 $4.26M
Current Liabilities Q2 2022 · Dec 31, 2021 $2.76M
Total Liabilities Q2 2022 · Jun 30, 2022 $4.46M
Total Liabilities Q2 2022 · Dec 31, 2021 $4.41M
Current Assets Q2 2022 · Jun 30, 2022 $2.38M
Current Assets Q2 2022 · Dec 31, 2021 $2.18M
Total Assets Q2 2022 · Jun 30, 2022 $6.52M
Total Assets Q2 2022 · Dec 31, 2021 $6.77M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.25
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.76
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.09
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.16
Eps Basic Q2 2022 · Jun 30, 2022 −$0.25
Eps Basic Q2 2022 · Jun 30, 2022 −$0.76
Eps Basic Q2 2022 · Jun 30, 2021 −$0.09
Eps Basic Q2 2022 · Jun 30, 2021 −$0.16
Sga Expense Q2 2022 · Jun 30, 2022 $9.74M
Sga Expense Q2 2022 · Jun 30, 2022 $25.46M
Sga Expense Q2 2022 · Jun 30, 2021 $2.58M
Sga Expense Q2 2022 · Jun 30, 2021 $4.32M
Net Income Q2 2022 · Jun 30, 2022 −$9.8M
Net Income Q2 2022 · Jun 30, 2022 −$28.98M
Net Income Q2 2022 · Jun 30, 2021 −$2.71M
Net Income Q2 2022 · Jun 30, 2021 −$4.66M
Operating Income Q2 2022 · Jun 30, 2022 −$9.81M
Operating Income Q2 2022 · Jun 30, 2022 −$25.58M
Operating Income restated Q2 2022 · Jun 30, 2021 −$2.62M
Operating Income Q2 2022 · Jun 30, 2021 −$4.32M
Gross Profit Q2 2022 · Jun 30, 2022 $0
Gross Profit Q2 2022 · Jun 30, 2022 $0
Gross Profit Q2 2022 · Jun 30, 2021 $0
Gross Profit Q2 2022 · Jun 30, 2021 $75K
Cost Of Revenue Q2 2022 · Jun 30, 2022 $0
Cost Of Revenue Q2 2022 · Jun 30, 2022 $0
Cost Of Revenue Q2 2022 · Jun 30, 2021 $0
Cost Of Revenue Q2 2022 · Jun 30, 2021 $0
Revenue Q2 2022 · Jun 30, 2022 $0
Revenue Q2 2022 · Jun 30, 2022 $0
Revenue Q2 2022 · Jun 30, 2021 $0
Revenue Q2 2022 · Jun 30, 2021 $75K